Characterization of the effects of four HTR3B polymorphisms on human 5-HT3AB receptor expression and signalling

Pharmacogenetics and Genomics

Volumn 18, Issue 12, 2008, Pages 1027-1040

  Krzywkowski, Karen ^a   Davies, Paul A ^b   Irving, Andrew J ^c   Bräuner Osborne, Hans ^a   Jensen, Anders A ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

5 HT3A; 5 HT3AB; Expression; Function; Ligand gated ion channel; Polymorphism; S HT3B; Serotonin; Single nucleotide polymorphism; Variant

Indexed keywords

CELL SURFACE RECEPTOR; RECEPTOR SUBUNIT; SEROTONIN 3 RECEPTOR; SEROTONIN 3AB RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; DNA POLYMORPHISM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

CELL LINE; CELL MEMBRANE; ELECTROPHYSIOLOGY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HETEROZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; MUTANT PROTEINS; MUTATION; POLYMORPHISM, GENETIC; PROTEIN SUBUNITS; RECEPTORS, SEROTONIN; RECOMBINANT FUSION PROTEINS; SEROTONIN; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 57149129714     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e328310f950     Document Type: Article

References (38)

1. Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 2002; 71:533-554.
2. 3 receptors facilitates GABA release in the hippocampus: in vitro slice and synaptosome studies. Neuroscience 2004; 129:703-718.
3. 3 receptors facilitates glutamatergic synaptic inputs to area postrema neurons in rat brain slices. Methods Find Exp Clin Pharmacol 2004; 26:615-622.
4. Fink KB, Göthert M. 5-HT receptor regulation of neurotransmitter release. Pharmacol Rev 2007; 59:360-417.
5. 3 receptors in rat amygdala. Neuron 1992; 8:199-203.
6. 3 receptor. Scand J Rheumatol Suppl 2004; 119:2-8.
7. 3 receptor as a therapeutic target. Expert Opin Ther Targets 2007; 11:527-540.
8. Jensen AA, Frølund B, Liljefors T, Krogsgaard-Larsen P. Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J Med Chem 2005; 48:4705-4745.
9. Karlin A. Emerging structure of the nicotinic acetylcholine receptors. Nat Rev Neurosci 2002; 3:102-114.
10. Lynch JW. Molecular structure and function of the glycine receptor chloride channel. Physiol Rev 2004; 84:1051-1095.
11. Sieghart W, Sperk G. Subunit composition, distribution and function of GABAA receptor subtypes. Curt Top Med Chem 2002; 2:795-816.
12. 3 receptor: a model ligand-gated ion channel. Mol Membr Biol 2002;19:11-26.
13. Miyake A, Mochizuki S, Takemoto Y, Akuzawa S. Molecular cloning of human 5-tiydroxytiyptamine3 receptor: heterogeneity in distribution and function among species. Mol Pharmacol 1995; 48:407-416.
14. 3B subunit is a major determinant of serotonin-receptor function. Nature 1999; 397:359-363.
15. 3 aerotonin receptor-like genes HTR3C, HTR3D and HTR3E. Gene 2003; 310:101-111.
16. 3 receptors. Trends Pharmacol Sci 2008; 29:437-444.
17. 3 receptor mRNA. Proc Natl Acad Sci U S A 1903; 90:1430-1434.
18. 3E. Mol Pharmacol 2007; 72:8-17.
19. 3 receptors. Proc Natl Acad Sci U S A 2005; 102:12595-12600.
20. 3 receptor. Biophys J 2003; 84:1720-1733.
21. Levy S, Sutton G, Ng PC, Feuk L, Halpem AL, Walenz BP, et al. The diploid genome sequence of an individual human. PLoS Biol 2007; 5:e254.
22. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al. The sequence of the human genome. Science 2001; 291:1304-1351.
23. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409:860-921.
24. A receptor epilepsy mutations. Biochem Pharmacol 2004; 68:1497-1606.
25. Combi R, Dalprà L, Tenchini ML, Ferini-Strambi L. Autosomal dominant nocturnal frontal lobe epilepsy: a critical overview. J Neurol 2004; 251: 923-934.
26. 3 receptor function and expression. Pharmacogenet Genom 2007; 17: 255-266.
27. 3AB receptor. Proc Natl Acad Sci U S A 2008; 105:722-727.
28. Yamada K, Hattori E, Iwayama Y, Onnishi T, Ohba H, Toyota T, et al. Distinguishable haplotype blocks in the HTR3A and HTR3B region in the Japanese reveal evidence of association of HTR3B with female major depression. Biol Psychiatry 2006; 60:192-201.
29. Frank B, Niesler B, Bondy B, Spath M, Pongratz DE, Ackenheil M, et al. Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in fibromyalgia patients. Clin Rheumatol 2004; 23:338-344.
30. Frank B, Niesler B, Nöther. MM, Neidt H, Propping P, Bondy B, et al. Investigation of the human serotonin receptor gene HTR3B in bipolar affective and schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet 2004; 131:1-5.
31. Gutierrez B, Arranz MJ, Huezo-Diaz P, Dempster D, Matthiaseon P, Travis M, et al. Novel mutations in 5-HT3A and 5-HT3B receptor genes not associated with clozapine response. Schizophr Res 2002; 58:93-97.
32. Tremblay PB, Kaiser R, Sezer O, Rösler N, Schelenz C, Possinger K, et al. Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients. J Clin Oncol 2003; 21:2147-2155.
33. 3B receptor subunit. J Biol Chem 1999; 274:30799-30810.
34. Stevens R, Rusch D, Solt K, Raines DE, Davies PA. Modulation of human 5-hydroxytryptamine type 3AB receptors by volatile anesthetics and n-alcohols. J Pharmacol Exp Ther 2005; 314:338-345.
35. 3 receptor. J Biol Chem 2008; 283:6826-6831.
36. Niesler B, Weiss B, Fischer C, Nothen MM, Propping P, Bondy B, et al. Serotonin receptor gene HTR3A variants in schizophrenic and bipolar affective patients. Pharmacogenetics 2001; 11:21-27.
37. Brejc K, van Dijk WJ, Klaassen RV, Schuurmans M, van Der Oost J, Smit AB, et al. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 2001; 411:269-276.
38. Walstab J, Hammer C, Bonisch H, Rappold G, Niesler B. Naturally occurring variants in the HTR3B gene significantly alter properties of human heteromeric 5-hydroxytryptamine-3A/B receptors. Pharmacogenet Gemvrucs 2008; 18:793-802.